RE:RE:hahahahaha miners
this is completely different than most companies that re-invent themselves as the next hot thing in desperation of running out of money and time. I suspect this is initiated by an Israeli company that wanted to go public with little cost and be under the cdn system for tax purposes and get some cash to boot. They have a product that will in all likelihood become the gold standard worldwide for HEP treatment. If things go well with FDA. Original lvn shareholders will do very, very well. And they keep 50% of their original investment. Nothing is for certain however. Still risks involved